Discounted Cash Flow (DCF) Analysis Levered
G Medical Innovations Holdings Ltd (GMVD)
$3
+0.01 (+0.33%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 0.14 | 4.34 | 7.89 | 4.90 | 5.06 | 43.65 | 376.63 | 3,249.99 | 28,044.62 | 242,001.10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | - | - | - | -4.65 | -11.49 | -70.29 | -606.53 | -5,233.79 | -45,163.16 | -389,719.42 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -1.91 | -3.35 | -0.61 | -0.51 | -0.55 | -128.76 | -1,111.08 | -9,587.65 | -82,733.24 | -713,917.05 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -1.91 | -3.35 | -0.61 | -5.15 | -12.04 | -199.05 | -1,717.60 | -14,821.45 | -127,896.41 | -1,103,636.47 |
Weighted Average Cost Of Capital
| Share price | $ 3 |
|---|---|
| Beta | -1.132 |
| Diluted Shares Outstanding | 3.07 |
| Cost of Debt | |
| Tax Rate | 0.02 |
| After-tax Cost of Debt | 57.27% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | -1.826 |
| Total Debt | 7.84 |
| Total Equity | 9.21 |
| Total Capital | 17.06 |
| Debt Weighting | 45.98 |
| Equity Weighting | 54.02 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 0.14 | 4.34 | 7.89 | 4.90 | 5.06 | 43.65 | 376.63 | 3,249.99 | 28,044.62 | 242,001.10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | -4.65 | -11.49 | -70.29 | -606.53 | -5,233.79 | -45,163.16 | -389,719.42 |
| Capital Expenditure | -1.91 | -3.35 | -0.61 | -0.51 | -0.55 | -128.76 | -1,111.08 | -9,587.65 | -82,733.24 | -713,917.05 |
| Free Cash Flow | -1.91 | -3.35 | -0.61 | -5.15 | -12.04 | -199.05 | -1,717.60 | -14,821.45 | -127,896.41 | -1,103,636.47 |
| WACC | ||||||||||
| PV LFCF | -158.79 | -1,093.14 | -7,525.19 | -51,803.73 | -356,618.90 | |||||
| SUM PV LFCF | -417,199.74 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 25.35 |
| Free cash flow (t + 1) | -1,125,709.20 |
| Terminal Value | -4,821,024.42 |
| Present Value of Terminal Value | -1,557,821.31 |
Intrinsic Value
| Enterprise Value | -1,975,021.05 |
|---|---|
| Net Debt | 1.81 |
| Equity Value | -1,975,022.86 |
| Shares Outstanding | 3.07 |
| Equity Value Per Share | -643,114.45 |